))
Andrew Rudd w/ Alesmith
Série arquivada ("Feed inativo " status)
When?
This feed was archived on November 06, 2024 16:35 (
Why? Feed inativo status. Nossos servidores foram incapazes de recuperar um feed de podcast válido por um período razoável.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 305868198 series 2971598
Conteúdo fornecido por Daniel Schroeder. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Daniel Schroeder ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Andrew Rudd holds a PhD from UCSD and is the founder and CEO of Palm Therapeutics.
We shared some beer from Alesmith and talked about his company Palm and their work with Lipids. We also dug into the process of applying for grants and how that has been a valuable alternative to venture capital and what the next milestones are as they continue to grow.
18 episódios
Compartilhar
